Nucl Med Mol Imaging.
2013 Jun;47(2):81-88.
Differential Diagnosis of Borderline Ovarian Tumors from Stage I Malignant Ovarian Tumors using FDG PET/CT
- Affiliations
-
- 1Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea.
- 2Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.
- 3Department of Nuclear Medicine, Seoul National University Boramae Medical Center, Seoul, Korea. sowonoh@gmail.com
- 4Department of Molecular Medicine and Biopharmaceutical Sciences, WCU Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea.
- 5Department of Nuclear Medicine, Korea University Ansan Hospital, Ansan, Korea.
Abstract
- PURPOSE
Borderline ovarian tumors (BOTs) are more common in young women of reproductive age, and exhibit a better prognosis than malignant ovarian tumors (MOTs). Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) were compared in their ability to differentiate BOTs from stage I MOTs.
METHODS
Among 173 patients who had preoperative FDG PET/CT due to ovarian neoplasms between November 2006 and March 2009, there were 13 patients with BOTs or stage I MOTs. For differential diagnosis of the two tumors, cancer antigen-125 (CA-125) level, the longest diameter of tumors, metabolic indices including maximum standardized uptake value (SUVmax), and volumetric indices including metabolic tumor volume (MTV) were compared, respectively.
RESULTS
The BOT group (n=7) was comprised of five mucinous and two serous tumors, and the MOT group (n=6) was comprised of three endometrioid, two clear cell and one mucinous tumors. Among the comparisons between two groups, SUVmax of the BOT group was significantly lower than that of the MOT group (2.9+/-1.5 vs. 6.6+/-2.9, p=0.0223); otherwise, no significant difference was found in age, CA-125, diameter, or MTV. By receiver-operating characteristic curve analysis, SUVmax of 3.7 was the best cutoff value to differentiate BOTs from stage I MOTs, with a sensitivity of 83.3 % and specificity of 85.7, and the area under curve of 0.893 (p=0.0001, 95 % CI: 0.601~0.993).
CONCLUSIONS
We demonstrated that SUVmax could distinguish BOTs from stage I MOTs, with a high sensitivity and specificity. Metabolic indices determined by FDG PET/CT were more suitable than volumetric indices for differential diagnosis of the two tumors.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Expression of E-cadherin in Benign, Borderline, and Malignant Ovarian Epithelial Tumors
- Extremely elevated serum CA 125 in a borderline tumor of the ovary: A case report
- The Accuracy of Frozen Section in the Diagnosis of Ovarian Tumors
- Two Cases of Advanced Ovarian Serous Tumor of Borderline Malignancy
- Accuracy of frozen section diagnosis for ovarian tumors according to histologic type and malignant potential
